AU5189779A - Process for producing oxymorphone - Google Patents

Process for producing oxymorphone

Info

Publication number
AU5189779A
AU5189779A AU51897/79A AU5189779A AU5189779A AU 5189779 A AU5189779 A AU 5189779A AU 51897/79 A AU51897/79 A AU 51897/79A AU 5189779 A AU5189779 A AU 5189779A AU 5189779 A AU5189779 A AU 5189779A
Authority
AU
Australia
Prior art keywords
oxymorphone
producing
producing oxymorphone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51897/79A
Inventor
Michael L. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of AU5189779A publication Critical patent/AU5189779A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polarising Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU51897/79A 1978-10-19 1979-10-18 Process for producing oxymorphone Abandoned AU5189779A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95305678A 1978-10-19 1978-10-19
US953056 1992-09-30

Publications (1)

Publication Number Publication Date
AU5189779A true AU5189779A (en) 1980-04-24

Family

ID=25493512

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51897/79A Abandoned AU5189779A (en) 1978-10-19 1979-10-18 Process for producing oxymorphone

Country Status (16)

Country Link
JP (1) JPS55501025A (en)
AU (1) AU5189779A (en)
BE (1) BE879494A (en)
CA (1) CA1108132A (en)
CS (1) CS211364B2 (en)
DK (1) DK258280A (en)
ES (1) ES485154A1 (en)
FI (1) FI793235A (en)
FR (1) FR2439201A1 (en)
GB (1) GB2049680A (en)
IL (1) IL58489A0 (en)
IT (1) IT7969032A0 (en)
NL (1) NL7920126A (en)
NO (1) NO793297L (en)
SE (1) SE8004454L (en)
WO (1) WO1980000841A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5668285A (en) * 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
FR2636330B1 (en) * 1988-09-13 1990-11-30 Sanofi Sa PROCESS FOR THE PREPARATION OF MORPHINANE DERIVATIVES
WO1991005768A1 (en) * 1989-10-16 1991-05-02 The United States Of America, Represented By The Secretary, United States Department Of Commerce Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
CN1268338C (en) 2001-07-06 2006-08-09 恩德制药公司 Oral administration of 6-hydroxy-oxymorphone for use as antalgesic
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Break-resistant dosage forms with sustained release
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Anti-abuse dosage form
DE10361596A1 (en) 2003-12-24 2005-09-29 Grünenthal GmbH Process for producing an anti-abuse dosage form
DE102004032049A1 (en) 2004-07-01 2006-01-19 Grünenthal GmbH Anti-abuse, oral dosage form
DE102005005449A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Process for producing an anti-abuse dosage form
MX2008010921A (en) 2006-03-02 2008-09-03 Mallinckrodt Inc Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds.
EP2249811A1 (en) 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
WO2011009602A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Hot-melt extruded controlled release dosage form
BR112012001244A2 (en) 2009-07-22 2020-12-08 Gruünenthal Gmbh Tamper Resistant DOSAGE FORM, ITS PRODUCTION PROCESS, AND PACKAGING CONTAINING SUCH FORM
RU2604676C2 (en) 2010-09-02 2016-12-10 Грюненталь Гмбх Destruction-resistant dosage form containing an inorganic salt
AR082862A1 (en) 2010-09-02 2013-01-16 Gruenenthal Gmbh ALTERATION RESISTANT DOSAGE FORM INCLUDING AN ANIONIC POLYMER
BR112014002022A2 (en) 2011-07-29 2017-02-21 Gruenenthal Gmbh tamper-resistant tablet providing immediate drug release
PT2736497T (en) 2011-07-29 2017-11-30 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
CA2864949A1 (en) 2012-02-28 2013-09-06 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
ES2692944T3 (en) 2012-04-18 2018-12-05 Grünenthal GmbH Pharmaceutical dosage form resistant to handling and resistant to rapid discharge of the dose
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX2015016254A (en) 2013-05-29 2016-04-20 Gruenenthal Gmbh Tamper resistant dosage form with bimodal release profile.
MX371432B (en) 2013-05-29 2020-01-30 Gruenenthal Gmbh Tamper-resistant dosage form containing one or more particles.
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CN105934241B (en) 2013-11-26 2020-06-05 格吕伦塔尔有限公司 Preparation of powdered pharmaceutical composition by cryogenic grinding
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
CN107889459A (en) 2015-04-24 2018-04-06 格吕伦塔尔有限公司 Tamper resistant dosage form with release immediately and to solvent-extracted resistance
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
EP3252055B1 (en) 2016-05-31 2018-09-19 Alcaliber Investigacion Desarrollo e Innovacion SLU Process for obtaining 3,14-diacetyloxymorphone from oripavine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249616A (en) * 1966-05-03 Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof
US2806033A (en) * 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
NL7920126A (en) 1980-08-29
SE8004454L (en) 1980-06-16
ES485154A1 (en) 1980-06-16
DK258280A (en) 1980-06-17
FI793235A (en) 1980-04-20
NO793297L (en) 1980-04-22
GB2049680A (en) 1980-12-31
BE879494A (en) 1980-02-15
IL58489A0 (en) 1980-01-31
WO1980000841A1 (en) 1980-05-01
FR2439201A1 (en) 1980-05-16
CS211364B2 (en) 1982-02-26
IT7969032A0 (en) 1979-10-18
CA1108132A (en) 1981-09-01
JPS55501025A (en) 1980-11-27

Similar Documents

Publication Publication Date Title
AU5189779A (en) Process for producing oxymorphone
YU83079A (en) Process for producing iminoquinazoline
AU528488B2 (en) Shaping process
DE2966644D1 (en) Process for producing 2-chloro-5-trichloromethylpyridine
YU103679A (en) Process for producing azolopyriimidinones
HU184198B (en) Process for producing s-alpha-cyano-3-phenoxy-benzyl-alcohol
HU178089B (en) Process for producing imidazo-quinoxaline derivatives
SU915802A3 (en) Process for producing dibenzthiazolyldisulfide
AU527630B2 (en) Process for producing aryltrifluorethanols
HU178014B (en) Process for producing 5-cyano-4-methyl-oxazole
GB2018268B (en) Process for producing organosilanes
GB2029412B (en) Process for producing benzofurazan-1-oxides
GB2025953B (en) Process for producing 3 - hydroxi - 5 - halopyridines
HU178589B (en) Process for producing pyridie derivatives
GB2021560B (en) Process for producing ketazines
AU517313B2 (en) Apparatus for producing slurry
HU178357B (en) Process for producing thioalkanoiyl-pyrrolidine-carboxaldehyde derivatives
AU528245B2 (en) Process for producing phenoxyalkene derivative
SU913944A3 (en) Process for producing n-glucofuranozid-6-yl-n -nitrosocarbamides
HU178113B (en) Process for producing n-bracket-1-methyl-2-pyrolidinyl-methyl-bracket closed-2-3-dimethoxy-5-methyl-sulfamoyl-benzamide derivatives
HU177814B (en) Process for producing trisazo-colouring agent
HU179028B (en) Process for producing new d-homoo-steroides
HU178396B (en) Process for producing new 8-beta-hydrazion-methyl-ergoline-and -ergolene derivatives
YU137579A (en) Process for producing cyanurchloride
YU40221B (en) Process for producing cyanurchloride